Skip to main content
Monday, August 24, 2026
BTC $78,934 ▲ 1.54%
GOKHSHTEIN
.
Live Wire
Politics
World
Markets
Digital Assets
Technology
Sports
Sections
Franchises
The Brief
The Big Read
The Breakdown
Crypto Culture
More Sections
DeFi & On-Chain
U.S. Equities
Macro & Rates
Research
Subscribe
Menu
×
News
Live Wire
Politics
World
Markets
Digital Assets
Technology
Sports
Franchises
The Brief
The Big Read
The Breakdown
Crypto Culture
More
DeFi & On-Chain
U.S. Equities
Macro & Rates
Research
Subscribe
LIVE
ADA
$0.220
down
−2.77%
ETH
$2,475
up
+0.51%
LINK
$11.55
up
+0.09%
SOL
$95.87
up
+0.47%
BTC
$78,934
up
+1.54%
XRP
$1.48
down
−2.43%
S&P 500
7,655
down
−0.25%
Nasdaq
26,040
down
−0.54%
Dow
53,346
up
+0.13%
RUT
2,992
down
−0.85%
TNX
4.70%
down
−0.84%
TYX
5.23%
down
−0.93%
FVX
4.40%
down
−0.47%
IRX
3.71%
down
−0.08%
VIX
15.78
up
+4.30%
GOLD
$4,690.40
up
+0.21%
SILVER
$68.40
down
−1.63%
OIL
$84.77
down
−2.63%
DXY
99.05
up
+0.25%
NVDA
$209.70
down
−2.34%
AAPL
$311.77
up
+0.78%
TSLA
$354.28
down
−2.36%
META
$557.60
up
+1.40%
MSFT
$487.88
up
+0.96%
AMZN
$262.43
up
+1.47%
GOOGL
$348.70
up
+1.12%
Fear & Greed
73 — Greed
ADA
$0.220
down
−2.77%
ETH
$2,475
up
+0.51%
LINK
$11.55
up
+0.09%
SOL
$95.87
up
+0.47%
BTC
$78,934
up
+1.54%
XRP
$1.48
down
−2.43%
S&P 500
7,655
down
−0.25%
Nasdaq
26,040
down
−0.54%
Dow
53,346
up
+0.13%
RUT
2,992
down
−0.85%
TNX
4.70%
down
−0.84%
TYX
5.23%
down
−0.93%
FVX
4.40%
down
−0.47%
IRX
3.71%
down
−0.08%
VIX
15.78
up
+4.30%
GOLD
$4,690.40
up
+0.21%
SILVER
$68.40
down
−1.63%
OIL
$84.77
down
−2.63%
DXY
99.05
up
+0.25%
NVDA
$209.70
down
−2.34%
AAPL
$311.77
up
+0.78%
TSLA
$354.28
down
−2.36%
META
$557.60
up
+1.40%
MSFT
$487.88
up
+0.96%
AMZN
$262.43
up
+1.47%
GOOGL
$348.70
up
+1.12%
Fear & Greed
73 — Greed
Tag
Telehealth
3 articles
Research & Analysis
13d ago
Hims & Hers Beats Revenue Estimates but Cuts Profit Forecast on Growth Spending
Q2 revenue of $753.2 million topped estimates by 7.8 percent, but a trimmed full-year adjusted EBITDA forecast sent shares down 9.7 percent.
U.S. Equities
98d ago
Teladoc Faces Competitive Pressure as Growth Slows, Reimbursement Tightens
Teladoc's stretched valuation and profitability challenges make it a risky bet as telehealth adoption normalizes
U.S. Equities
130d ago
Hims & Hers Jumps on Peptide Reassessment: Multi-Billion Dollar Opportunity Unlocked
Hims & Hers Health, Inc. stock rallied sharply today after the U.S. government confirmed it would reassess the regulatory framework for popular peptides, signaling a substantial expansion opportunity for the telehealth provider.